Nov 26, 2019Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha RaAlpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...
Aug 22, 2018Alpha Tau’s High-Precision Cancer Radiotherapy Receives Radioactive-Safety Approval in the United StThe new Sealed Source and Device (SSD) approval enables the commencement of clinical trials in leading hospitals across the U.S. with the...
Aug 22, 2018Israeli Medical Startups Beat a Path to Aging Japan[..] Another company from Tel Aviv, Alpha Tau Medical, has partnered with Japanese biotechnology startup HekaBio to release radiation...
Jul 15, 2018CEO Uzi Sofer Reveals Great News on Galatz Radio 02.07.2018Alpha Tau Medical focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) for...